Trial Profile
Multicenter randomized phase II study of methotrexate (MTX) and temozolomide versus MTX, procarbazine, vincristine and cytarabine for primary CNS [central nervous system] lymphoma (PCNSL) in the elderly.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Methotrexate (Primary) ; Temozolomide (Primary) ; Cytarabine; Procarbazine; Vincristine
- Indications Lymphoma
- Focus Therapeutic Use
- 17 Aug 2007 New trial record.